05/20/2025
4:13 PM | Teva Pharmaceutical Industries (Subject)
| Form FWP | |
05/19/2025
5:50 AM | Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Finance Netherlands IV B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
| Form 424B5 | |
05/08/2025
1:34 PM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form DEF 14A | |
04/07/2025
3:01 PM | Lippman Evan (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2025
3:22 PM | McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:25 PM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:29 PM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:13 PM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:16 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TEVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. |
03/07/2025
3:19 PM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:06 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:08 PM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:11 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:13 PM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:29 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
3:08 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:14 PM | McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
03/04/2025
5:57 PM | McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:02 PM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:30 PM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:37 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:44 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
12:07 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
11:59 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
12:14 PM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
10:52 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
11:38 AM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
7:06 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
3:06 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
6:03 PM | BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
3:04 PM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
10:39 AM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
11/06/2024
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
6:40 AM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:06 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/14/2024
5:24 AM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
08/12/2024
3:09 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:32 AM | Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:35 AM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:30 AM | Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2024
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:00 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:03 AM | Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:38 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:41 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:23 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:27 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:14 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:17 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:20 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:45 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:47 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:49 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:51 AM | Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:53 AM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:36 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:38 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:42 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:31 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:33 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:25 AM | Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:18 AM | Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Buy TEVA Stock Free TEVA Stock Alerts